Submission Details
| 510(k) Number | K901333 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 20, 1990 |
| Decision Date | April 02, 1990 |
| Days to Decision | 13 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | — |
K901333 is an FDA 510(k) clearance for the BETA-2 MICROGLOBULIN EIA, a System, Test, Beta-2-microglobulin Immunological (Class II — Special Controls, product code JZG), submitted by Serex, Inc. (Tenafly, US). The FDA issued a Cleared decision on April 2, 1990, 13 days after receiving the submission on March 20, 1990. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5630.
| 510(k) Number | K901333 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 20, 1990 |
| Decision Date | April 02, 1990 |
| Days to Decision | 13 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | — |
| Product Code | JZG — System, Test, Beta-2-microglobulin Immunological |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5630 |